Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Q32 Bio (QTTB) Reiterated at Overweight by Cantor Fitzgerald
-
Londian Wason closes over-allotment option, raising $108M in IPO
-
Form 424B3 Cantor Fitzgerald Income
-
Cantor Fitzgerald Reiterates Overweight Rating on MiMedx Group (MDXG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Nyxoah SA (NYXH)
-
Cantor Fitzgerald Reiterates Overweight Rating on NeuroPace Inc (NPCE)
-
Cantor Fitzgerald: Robinhood Markets (HOOD) Best Positioned to Benefit From Institutional Adoption of Prediction Markets
-
New Sabre industry study finds travel companies making next AI moves amid maneuvering macroeconomic 'fog'
-
Cantor Fitzgerald Starts Samsara Inc (IOT) at Overweight
-
Cantor Fitzgerald Starts Autodesk (ADSK) at Neutral
-
Cantor Fitzgerald Starts Bentley Systems Inc. (BSY) at Overweight
-
Cantor Fitzgerald Starts Procore Technologies, Inc (PCOR) at Overweight
-
Orchid Island Capital Announces September 2026 Monthly Dividend and August 31, 2026 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Reiterates Overweight Rating on Pharvaris B.V. (PHVS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tyra Biosciences (TYRA)
-
Cantor Fitzgerald: 'The Case for Buying ASML Today'
-
Cantor Fitzgerald Upgrades 4D Molecular Therapeutics (FDMT) to Overweight
-
Tyra Biosciences prices $400 million stock offering at $22.03
-
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
Elmet Group to deploy $450M U.S. DoW investment in tungsten supply
-
Pentagon invests $450M in Elmet Group to boost tungsten supply chain
-
The Elmet Group to Deploy Strategic Capital to Strengthen U.S. and Allied Tungsten Supply Chain
-
Department of War Makes Landmark $450 Million Committed Investment in The Elmet Group to Secure America’s Tungsten Supply Chain
-
Londian Wason (NYSE:FOIL) Closes Partial Over-Allotment Option Exercise, Raising Over USD108 Million in Total IPO Proceeds
-
Exclusive-White House weighs how to use Defense Production Act to expand US oil refining capacity, sources say
-
Oklo launches new $1B at-the-market stock offering program
-
MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
-
MannKind (MNKD) Reiterated at Overweight by Cantor Fitzgerald on Positive MNKD-201 Ph1 Data
-
Cytokinetics (CYTK) Reiterated at Overweight by Cantor Fitzgerald
-
Incyte (INCY) Reiterated at Neutral by Cantor Fitzgerald After Management Chat
-
Oracle (ORCL) Reiterated at Overweight by Cantor Fitzgerald on Strong Q1 Results
-
UnitedHealth Group (UNH) Reiterated at Overweight by Cantor Fitzgerald
-
Molina Healthcare (MOH) Reiterated at Neutral by Cantor Fitzgerald
-
Humana (HUM) Reiterated at Neutral by Cantor Fitzgerald
-
Elevance (ELV) Reiterated at Overweight by Cantor Fitzgerald
-
CVS Health (CVS) Reiterated at Overweight by Cantor Fitzgerald
-
Centene (CNC) Reiterated at Overweight by Cantor Fitzgerald
-
Arcus Biosciences (RCUS) Reiterated at Overweight by Cantor Fitzgerald After CFO Chat
-
Twenty-five years after September 11, Americans reflect on attack that changed a nation
-
Good Greek Founder Spero Georgedakis Remembers Childhood Friend John Katsimatides on 25th Anniversary of 9/11
-
Cantor Fitzgerald Reiterates Overweight Rating on DBV Technologies S.A (DBVT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Aquestive Therapeutics (AQST)
-
Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tyra Biosciences (TYRA)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenax Therapeutics (TENX)
-
Cantor Fitzgerald Reiterates Neutral Rating on Centerspace (CSR) on IRT Deal
-
Stifel Deepens Fixed Income Platform with Senior Talent
-
2,977 LIGHTS RISE OVER NEW YORK HARBOR AND REBUILD THE TWIN TOWERS IN LIGHT
-
Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
-
Braze (BRZE) Reiterated at Overweight by Cantor Fitzgerald on Solid Q2 Results
